These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12738034)

  • 1. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
    Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
    J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a key amino acid of the human 5-HT(2B) serotonin receptor important for sarpogrelate binding.
    Muntasir HA; Hossain M; Bhuiyan MA; Komiyama T; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2007 Jul; 104(3):274-7. PubMed ID: 17609583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis.
    Manivet P; Schneider B; Smith JC; Choi DS; Maroteaux L; Kellermann O; Launay JM
    J Biol Chem; 2002 May; 277(19):17170-8. PubMed ID: 11859080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG; Fang L; Huang Y; Wilczynski A; Sivendran S
    Eur J Pharmacol; 2009 Aug; 615(1-3):1-9. PubMed ID: 19397907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.
    Muntasir HA; Bhuiyan MA; Ishiguro M; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2006 Oct; 102(2):189-95. PubMed ID: 17031071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of amino acid residues important for sarpogrelate binding to the human 5-hydroxytryptamine2A serotonin receptor.
    Muntasir HA; Rashid M; Komiyama T; Kawakami J; Nagatomo T
    J Pharmacol Sci; 2006 Sep; 102(1):55-63. PubMed ID: 16974069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors.
    Gleason SD; Lucaites VL; Shannon HE; Nelson DL; Leander JD
    Behav Pharmacol; 2001 Dec; 12(8):613-20. PubMed ID: 11856898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
    Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed mutagenesis of the serotonin 5-Hydroxytryptamine2c receptor: identification of amino acids responsible for sarpogrelate binding.
    Muntasir HA; Takahashi J; Rashid M; Ahmed M; Komiyama T; Hossain M; Kawakami J; Nashimoto M; Nagatomo T
    Biol Pharm Bull; 2006 Aug; 29(8):1645-50. PubMed ID: 16880620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist binding at 5-HT(2A) and 5-HT(2C) receptors in the rabbit: high correlation with the profile for the human receptors.
    Aloyo VJ; Harvey JA
    Eur J Pharmacol; 2000 Oct; 406(2):163-9. PubMed ID: 11020478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.
    Nishio H; Inoue A; Nakata Y
    Arch Int Pharmacodyn Ther; 1996; 331(2):189-202. PubMed ID: 8937629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
    Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
    Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1.
    Becamel C; Figge A; Poliak S; Dumuis A; Peles E; Bockaert J; Lubbert H; Ullmer C
    J Biol Chem; 2001 Apr; 276(16):12974-82. PubMed ID: 11150294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.
    De Deurwaerdère P; Spampinato U
    J Neurochem; 1999 Sep; 73(3):1033-42. PubMed ID: 10461892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of structural determinants of ligand selectivity in 5-HT₂ receptor subtypes on the basis of protein-ligand interactions.
    Jang JW; Kim MS; Cho YS; Cho AE; Pae AN
    J Mol Graph Model; 2012 Sep; 38():342-53. PubMed ID: 23085173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats.
    Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
    Behav Pharmacol; 2002 Jul; 13(4):313-8. PubMed ID: 12218512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.